Corbenic Partners LLC Ampio Pharmaceuticals, Inc. Transaction History

Corbenic Partners LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Jan 25, 2018	SELL	$0.68 - $4.19 $2,720 - $16,760	-4,000 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	4,000	4,000 $2,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $22.6M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Corbenic Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Corbenic Partners LLC with notifications on news.